RT Journal Article
SR Electronic
A1 Sinclair, Heather Q.
T1 Results from the ACCORD Lipid Study
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 2
SP 11
OP 11
DO 10.1177/155989771002003
UL http://mdc.sagepub.com/content/10/2/11.abstract
AB The Action to Control Cardiovascular Risk in Diabetes [ACCORD] Lipid study [NCT00000620] does not support the use of combination fibrate and statin therapy compared with statin therapy alone to reduce cardiovascular risk in high-risk patients with type 2 diabetes mellitus. However, subgroup analyses suggest a treatment interaction that is associated with combination therapy and gender and a possible interaction between combination therapy and severe dyslipidemia.